ECS10
CORRECTING PRESBYOPIA IN YOUNG PATIENTS WITH THE PHAKIC ARTIPLUS LENS
J. Guëll1,*
1IMO Instituto de Microcirugía Ocular, Barcelona, Spain
Ophtec is a family owned business that develops ingenious lenses, different from the usual market concepts.
The Artiplus phakic IOL is such an ingenuous lens. It is an iris fixated lens that makes use of the unique patented CTF (Continuous Transitional Focus) technology that allows correction of presbyopia in young patients that still have a healthy crystalline lens.
This unique solution corrects myopic presbyopes, hyperopic presbyopes and ametropic presbyopes allowing patients to keep their natural crystalline lens. For young eyes, where there is still some degree of accommodation, this represents an extra benefit resulting in an outstanding quality of vision as the first clinical results show while providing high levels of spectacle independence. The Artiplus solution is also reversible offering the possibility to explant the lens easily.